PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 34 filers reported holding PROTARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $182,679 | +272555.2% | 58,364 | +233356.0% | 0.00% | – |
Q4 2022 | $67 | -93.3% | 25 | -89.8% | 0.00% | – |
Q3 2022 | $1,000 | -85.7% | 244 | -90.1% | 0.00% | – |
Q2 2022 | $7,000 | -78.8% | 2,454 | -62.6% | 0.00% | – |
Q1 2022 | $33,000 | -82.4% | 6,556 | -76.5% | 0.00% | – |
Q4 2021 | $188,000 | +2.2% | 27,900 | +5.0% | 0.00% | – |
Q3 2021 | $184,000 | -61.3% | 26,582 | -45.6% | 0.00% | – |
Q2 2021 | $475,000 | +2161.9% | 48,884 | +3505.0% | 0.00% | – |
Q1 2021 | $21,000 | -84.3% | 1,356 | -75.4% | 0.00% | – |
Q4 2020 | $134,000 | +3250.0% | 5,504 | +2252.1% | 0.00% | – |
Q3 2020 | $4,000 | -78.9% | 234 | -64.2% | 0.00% | – |
Q2 2020 | $19,000 | – | 653 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |